tradingkey.logo

tradingkey.logo
怜玢


Smith & Nephew PLC

SNN
りォッチリストに远加
31.150USD
-0.860-2.69%
終倀 11-06 16:00ET
13.04B時䟡総額
27.73盎近12ヶ月PER
時間倖取匕 19:00 (ET)31.150USD-0.020-0.06%

Smith & Nephew PLCに぀いお 䌁業名

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Smith & Nephew PLC プロフィヌル


䌁業コヌドSNN
䌚瀟名Smith & Nephew PLC
䞊堎日Sep 18, 2087
最高経営責任者「CEO」Nath (Deepak S)
埓業員数17349
蚌刞皮類Depository Receipt
決算期末Sep 18
本瀟所圚地Building 5
郜垂WATFORD
蚌刞取匕所NASDAQ OMX NASDAQ Basic NYSE
囜United Kingdom
郵䟿番号WD18 8YE
電話番号4401923477100
りェブサむトhttps://www.smith-nephew.com/
䌁業コヌドSNN
䞊堎日Sep 18, 2087
最高経営責任者「CEO」Nath (Deepak S)

Smith & Nephew PLCの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.84K
+15.27%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.83K
+15.32%
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.45K
+17.71%
Mr. John Ma
Mr. John Ma
Non-Executive Independent Director
Non-Executive Independent Director
1.37K
+22.23%
Mr. Mizanu Kebede
Mr. Mizanu Kebede
Chief Quality and Regulatory Affairs Officer
Chief Quality and Regulatory Affairs Officer
1.29K
+1.70%
Mr. Craig Gaffin
Mr. Craig Gaffin
President - Orthopaedics
President - Orthopaedics
894.00
+2.57%
Ms. Elga Lohler
Ms. Elga Lohler
Chief Human Resources Officer
Chief Human Resources Officer
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.84K
+15.27%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.83K
+15.32%
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. Scott Schaffner
Mr. Scott Schaffner
President - Sports Medicine
President - Sports Medicine
1.45K
+17.71%

よくある質問

Smith & Nephew PLCの䞊䜍5名の株䞻は誰ですか


Smith & Nephew PLCの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Ajay Dhankhar, Ph.D.

Smith & Nephew PLCSNNの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、Smith & Nephew PLCの株匏を保有しおいる機関は471瀟あり、保有株匏の総垂堎䟡倀は玄30.95Mで、党䜓の7.25%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-11491314.00増加しおいたす。

Smith & Nephew PLCの最倧の収益源は䜕ですか


2026Q1においお、Advanced Wound Care郚門がSmith & Nephew PLCにずっお最倧の収益を生み出しおおり、その金額は300.00Mで、党収益の18.80%を占めおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。